Developing new methods for creating medicinal compounds from basic materials
Innovative Transformations of Fundamental Synthetic Building Blocks
This study is all about finding better and faster ways to make new medicines by discovering new chemical reactions, which could help create important drugs more easily for people who need them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10840530 on NIH RePORTER |
What this research studies
This research focuses on improving the process of chemical synthesis to create new medicinal agents more efficiently. By exploring innovative transformations of fundamental building blocks, the project aims to discover new chemical reactions that can streamline drug development. The approach involves site-selective transformations of aliphatic C–H bonds, which could lead to the rapid creation of novel compounds that are important for biomedical applications. The research seeks to overcome current limitations in synthetic capabilities to enhance the availability of drug-like substances.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with conditions that require new or improved drug therapies.
Not a fit: Patients who are not seeking new treatment options or those with conditions that are already well-managed may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more efficient development of new medications.
How similar studies have performed: Other research has shown promise in similar approaches to chemical synthesis, indicating potential for success in this innovative area.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Alexanian, Erik John — Univ of North Carolina Chapel Hill
- Study coordinator: Alexanian, Erik John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.